EUVIMEDEUVIMED entdecken
Crossref

Association Between Kita-Kyushu Lung Cancer Antigen-1 Positivity and Pathological High-grade Lung Adenocarcinoma

Yasuto Kondo, Takashi Fukuyama, Dai Sonoda, Satoru Tamagawa, Yukiko Matsuo, Toshihide Matsumoto, Masaaki Ichinoe, Shinya Okada, Yukitoshi Satoh

Anticancer Research · 2026

DOI: 10.21873/anticanres.18353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yasuto Kondo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma, Antigens, Neoplasm, Biomarkers, Tumor.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer-testis antigen that represents a promising target for treatment with T-cell receptor (TCR) gene-engineered T cells. This study aimed to evaluate the utility of immunohistochemical detection of KK-LC-1 in resected lung adenocarcinoma specimens. PATIENTS AND METHODS: We reviewed the medical records of 110 patients who underwent curative resection for lung adenocarcinoma. The original monoclonal antibody against KK-LC-1, Kmab34B3, was evaluated in this study. Overall survival (OS) and recurrence-free survival (RFS) were compared based on KK-LC-1 positivity and epidermal growth factor receptor (EGFR) mutation. Cox regression analyses were performed to identify prognostic factors. RESULTS: Thirty-nine patients (35%) were positive for KK-LC-1. KK-LC-1 positivity was significantly associated with larger invasive tumor size, advanced pathological stage, lymphatic invasion, vascular invasion, and lymph node metastasis. No significant difference in OS was observed between KK-LC-1-positive and -negative patients (5-year OS: 79.8% vs. 94.0%, p=0.07). However, KK-LC-1-positive patients had significantly poorer RFS than KK-LC-1-negative patients (5-year RFS: 67.7% vs. 85.5%, p=0.020). In multivariate analysis, KK-LC-1 positivity was not an independent predictor of RFS (hazard ratio=1.230, p=0.63). EGFR mutation analysis was available for 89 patients, of whom 45 (50.5%) harbored EGFR mutations. In the EGFR mutation-positive subgroup, KK-LC-1-positive patients had significantly poorer OS than KK-LC-1-negative patients (5-year OS: 77.0% vs. 100%, p=0.026). RFS also tended to be poorer in KK-LC-1-positive patients, although the difference did not reach statistical significance (5-year RFS: 66.6% vs. 88.4%, p=0.055). CONCLUSION: KK-LC-1 positivity was significantly associated with pathological high-grade tumors and poor RFS in patients with lung adenocarcinoma. Moreover, KK-LC-1 may serve as a prognostic factor for lung adenocarcinoma, and KK-LC-1-positive patients may be suitable candidates for TCR reconstitution therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinomaAntigens, NeoplasmBiomarkers, TumorHumansMaleFemaleAgedMiddle AgedAdenocarcinoma of LungPrognosisErbB ReceptorsMutationNeoplasm GradingImmunohistochemistryAdultAged, 80 and over

Stichwörter der Autor:innen

KK-LC-1T-cell receptor therapyimmunohistochemistrylung adenocarcinomaprognostic biomarker

Substanzen

ErbB ReceptorsAntigens, NeoplasmBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
  • Department of Thoracic Surgery, Kitasato University Medical Center, Kitamoto, Japan.
  • Department of Microbial Chemistry and Medicinal Research Laboratories, Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan; fukuyam@insti.kitasato-u.ac.jp.
  • Department of Biological Chemistry and Food Sciences, Faculty of Agriculture, Iwate University, Morioka, Japan.
  • Department of Pathology, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
  • Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.

Zitieren

APA

Kondo, Y., Fukuyama, T., Sonoda, D., Tamagawa, S., Matsuo, Y., Matsumoto, T., Ichinoe, M., Okada, S., & Satoh, Y. (2026). Association Between Kita-Kyushu Lung Cancer Antigen-1 Positivity and Pathological High-grade Lung Adenocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.18353

Vancouver

Kondo Y, Fukuyama T, Sonoda D, Tamagawa S, Matsuo Y, Matsumoto T, et al. Association Between Kita-Kyushu Lung Cancer Antigen-1 Positivity and Pathological High-grade Lung Adenocarcinoma. Anticancer Research. 2026. doi:10.21873/anticanres.18353

BibTeX
@article{Kondo2026,
  author = {Kondo, Yasuto and Fukuyama, Takashi and Sonoda, Dai and Tamagawa, Satoru and Matsuo, Yukiko and Matsumoto, Toshihide and Ichinoe, Masaaki and Okada, Shinya and Satoh, Yukitoshi},
  title = {Association Between Kita-Kyushu Lung Cancer Antigen-1 Positivity and Pathological High-grade Lung Adenocarcinoma},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18353}
}
Kostenlos starten →